Physiological Roles of Glycogen Synthase Kinase-3: Potential as a Therapeutic Target for Diabetes and Other Disorders
Journal:
Current Drug Targets - Immune, Endocrine & Metabolic Disorders
Volume:
3
Page:
281-290
Author(s):
J. R. Woodgett
Approaches to Improve Cellular Retention of Radiohalogen Labels Delivered by Internalising Tumour-Targeting Proteins and Peptides
Journal:
Current Medicinal Chemistry
Volume:
10
Page:
2447-2460
Author(s):
V. Tolmachev, A. Orlova and H. Lundqvist
Genomic Instability and Cancer
Journal:
Current Molecular Medicine
Volume:
3
Page:
589-596
Author(s):
George S. Charames and Bharati Bapat
The Quest for a Tumor Suppressor Gene Phenotype
Journal:
Current Molecular Medicine
Volume:
3
Page:
605-629
Author(s):
Nadege Presneau, Emily N. Manderson and Patricia N. Tonin
Topoisomerases and Tubulin Inhibitors: A Promising Combination for Cancer Treatment
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
3
Page:
421-429
Author(s):
E. Rudolf and M. Cervinka
Identification and Targeting of Tumor Escape Mechanisms: A New Hope for Cancer Therapy?
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
2009-2023
Author(s):
Elke S. Bergmann-Leitner, Elizabeth H. Duncan and Wolfgang W. Leitner
Src Family Kinases: Potential Targets for the Treatment of Human Cancer and Leukemia
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
2043-2059
Author(s):
Markus Warmuth, Robert Damoiseaux, Yi Liu, Doriano Fabbro and Nathanael Gray
Preface [Hot topic: Tumour-Selective Drug Activation (Executive Editor : L.H. Patterson)]
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
i-i
Author(s):
L. H. Patterson
Enzyme / Abzyme Prodrug Activation Systems: Potential Use in Clinical Oncology
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
2113-2130
Author(s):
Yoshisuke Nishi
Prodrugs in Genetic Chemoradiotherapy
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
2131-2154
Author(s):
Adam V. Patterson, Mark P. Saunders and Olga Greco